- Open
- 7.25
- High
- 7.50
- Low
- 7.06
- Close
- 7.06
- Change
- -0.25 (-3.45%)
- Volume
- 258
| 27 Jul 2026 | 14:46:49 | Share option award |
| 15 Jul 2026 | 12:01:58 | Director/PDMR Shareholding |
| 13 Jul 2026 | 07:00:09 | HD Industry Update |
| 7 Jul 2026 | 07:00:01 | Trading Update |
| 19 Jun 2026 | 07:00:06 | Exercise of Options |
| 22 Jan 2026 | Annual Report and Accounts (to 2025-09-30) | |
| 6 Jan 2025 | Annual Report and Accounts (to 2024-09-30) | |
| 1 Jan 2025 | ANNUAL REPORT 2025 |
Ixico plc provides specialist data analytics services to the global biopharmaceutical industry, focusing on the collection, analysis, management, and reporting of data from clinical studies. Its services aim to enhance patient selection, monitor drug safety, and evaluate the clinical efficacy of drug candidates. The company primarily serves clients involved in the development of treatments for neurodegenerative diseases and operates internationally within the biopharmaceutical sector.
| 27 Jul 2026 | 14:46:49 | Share option award |
| 15 Jul 2026 | 12:01:58 | Director/PDMR Shareholding |
| 13 Jul 2026 | 07:00:09 | HD Industry Update |
| 7 Jul 2026 | 07:00:01 | Trading Update |
| 19 Jun 2026 | 07:00:06 | Exercise of Options |
| 22 Jan 2026 | Annual Report and Accounts (to 2025-09-30) | |
| 6 Jan 2025 | Annual Report and Accounts (to 2024-09-30) | |
| 1 Jan 2025 | ANNUAL REPORT 2025 |
Ixico plc provides specialist data analytics services to the global biopharmaceutical industry, focusing on the collection, analysis, management, and reporting of data from clinical studies. Its services aim to enhance patient selection, monitor drug safety, and evaluate the clinical efficacy of drug candidates. The company primarily serves clients involved in the development of treatments for neurodegenerative diseases and operates internationally within the biopharmaceutical sector.
| Issuer | Mkt cap | 1Y |
|---|---|---|
| £1.58bn | -0.2% | |
| £119m | +0.1% | |
| £61m | +1.8% | |
| £10m | -0.6% | |
IXIIxico PLC | £7m | -0.4% |
| £6m | -0.4% |
| Issuer | Mkt cap | 1Y |
|---|---|---|
| £1.58bn | -0.2% | |
| £119m | +0.1% | |
| £61m | +1.8% | |
| £10m | -0.6% | |
IXIIxico PLC | £7m | -0.4% |
| £6m | -0.4% |
